Xconomy

From Eleven Biotherapeutics Raises $35M, Seeks to Crank the Amplifer Up on Protein Drugs:

marklevin
marklevin

Mark Levin is a founding partner of Third Rock Ventures.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.